BioMarin Pharmaceutical
BMRN
$76.78
Share price
-4.50%
Change (1 day)
-19.33%
Change (1 year)
Categories
BioMarin Pharmaceutical (BMRN) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $1.79 B
According to BioMarin Pharmaceutical's latest financial reports the company's total liabilities are $1.79 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
BioMarin Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $1.89 B | 6.67% |
| 2022-12-31 | $1.77 B | 1.89% |
| 2021-12-31 | $1.73 B | -0.17% |
| 2020-12-31 | $1.74 B | 11.12% |
| 2019-12-31 | $1.56 B | 7.43% |
| 2018-12-31 | $1.45 B | -20.02% |
| 2017-12-31 | $1.82 B | 45.1% |
| 2016-12-31 | $1.25 B | -5.35% |
| 2015-12-31 | $1.32 B | 40.22% |
| 2014-12-31 | $0.94 B | 4.92% |
| 2013-12-31 | $0.90 B | 63.42% |
| 2012-12-31 | $0.55 B | 3.74% |
| 2011-12-31 | $0.53 B | -2.33% |
| 2010-12-31 | $0.54 B | -8.34% |
| 2009-12-31 | $0.59 B | -5.56% |
| 2008-12-31 | $0.63 B | 0.39% |
| 2007-12-31 | $0.62 B | 81.57% |
| 2006-12-31 | $0.34 B | 26.71% |
| 2005-12-31 | $0.27 B | -9.36% |
| 2004-12-31 | $0.30 B | 117.31% |
| 2003-12-31 | $0.13 B | 1047.08% |
| 2002-12-31 | $12.07 M | -1.55% |
| 2001-12-31 | $12.26 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $57.61 B | 3,102.75% | 🇫🇷 France |
 Ultragenyx RARE | $1.21 B | -32.42% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $82.43 M | -95.42% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.66 B | -63.27% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.61 B | -65.66% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $82.23 M | -95.43% | 🇺🇸 USA |